4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program [Yahoo! Finance]
ATLATL Announces Agreement with Daiichi Sankyo to Deepen APAC Biotech Innovation [Yahoo! Finance]
Can Tempus AI's (TEM) ALERT Trial Quietly Redefine Its Real-World Data Advantage in Cardiology? [Yahoo! Finance]
Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo [Seeking Alpha]
Tempus AI Daiichi Sankyo Tie Up Highlights Precision Oncology Opportunity [Yahoo! Finance]